Search Results 121-130 of 17457 for CLL
-
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or ...
-
Research. Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer.
-
Chronic lymphocytic leukemia is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. It most commonly ...
-
A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls Rochester, MN.
-
Focus areas · Decision-making for older adults with advanced cancers. Dr. · Managing older adults with chronic lymphocytic leukemia (CLL). CLL mainly affects ...
-
Diagnosis of chronic lymphocytic leukemia (CLL) according to the National Cancer Institute (NCI) criteria or small lymphocytic lymphoma (SLL) according to ...
-
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
-
Mayo Clinic researcher Asher A. Chanan-Khan, M.D., investigates treatments for chronic lymphocytic leukemia (CLL), Waldenstrom macroglobulinemia and ...
-
... chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Participation eligibility. Participant eligibility includes age, gender, type and ...
-
This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...